AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Dec 19 2020
News
Moderna, McKesson and U.S. Army general ready to roll out new COVID-19 vaccine
U.S. distribution of a second COVID-19 vaccine, from Moderna, is ready to start shipping to more than 3,800 sites this weekend, vastly widening the rollout begun last week with Pfizer, the drug company and distributor McKesson said.
ReutersNov 22 2021
Analysis
MSNBC's Joy Reid's false 'fact-check' claims Moderna, Pfizer not part of Operation Warp Speed
MSNBC host Joy Reid got her facts wrong when she attempted to fact-check GOP lawmakers who credited Operation Warp Speed for progress in the development of a coronavirus vaccine.
Moderna announced on Monday that interim analysis from a late-stage clinical trial showed its vaccine is 94.5% effective. On Wednesday, Pfizer followed that up with an announcement that its vaccine had been
Fox News (Online News)Oct 29 2020
News
Moderna says it's on track to report initial COVID-19 vaccine results next month
Moderna is on track to report initial results from its coronavirus vaccine trial next month, company executives said Thursday.
The company is one of the front-runners to produce a vaccine for COVID-19. During an earnings call, Chief Medical Officer Tal Zaks said the trial is operating as planned, and an independent data-monitoring committee is expected to conduct an interim review in
The HillOct 14 2021
News
FDA vaccine advisers recommend emergency use authorization for booster dose of Moderna's Covid-19 vaccine
Vaccine advisers to the US Food and Drug Administration voted unanimously Thursday to recommend emergency use authorization of a booster dose of Moderna's Covid-19 vaccine.
The FDA's Vaccines and Related Biological Products Advisory Committee agreed use of a booster dose would be safe and effective in some people six months out from their primary series.
Moderna had asked for
CNN (Online News)Jun 28 2021
News
Pfizer And Moderna Vaccines May Offer Years-Long Protection Against Covid-19, Scientists Say
Both the Pfizer-BioNTech and Moderna vaccines are likely to offer long-lasting protection against Covid-19, according to a study published on Monday, indicating that people who are already inoculated with either of the mRNA vaccines may not need a booster dose for years.
ForbesMar 23 2024
News
The Boston area built a ton of lab space. Now many of those buildings are opening empty.
Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs. The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier. But many biotech companies,
Boston.comOct 29 2020
News
Moderna reaches target goal of 30,000 vaccine trial participants, could apply for market in December
A Moderna COVID-19 vaccine clinical trial in the U.S. is underway and has reached the 30,000 participant target. The vaccine is one of four U.S vaccines in the phase 3 stage of trial.
The company says it's on track to apply for authorization from the Food and Drug Administration in early December if all requirements are met.
Of the 30,000 participants enrolled in the trial, half
Just The NewsFeb 23 2022
News
CDC says waiting longer between Pfizer, Moderna doses may reduce rare myocarditis risk for younger men
The U.S. Centers for Disease Control and Prevention said this week that younger males should consider waiting longer between doses of Pfizer’s and Moderna’s vaccines to reduce a rare risk of heart inflammation.
The CDC said males ages 12- to 39-years-old should consider waiting eight weeks between the first and second doses of their primary Covid vaccination series. Public health
CNBCNov 11 2021
News
Moderna says Covid vaccine has fewer breakthrough cases than Pfizer’s, but higher myocarditis rates in young men
Moderna defended the use of its Covid-19 vaccine Thursday, saying the protection it offers against severe disease, hospitalization and death outweighs the risk of myocarditis, a rare heart condition seen in a small number of young men who received the shot.
The company announced last week that the Food and Drug Administration needed more time to decide whether to authorize its two-dose
CNBCJan 18 2021
News
CDC, FDA Investigating California Moderna Covid-19 Vaccine Lot With ‘Higher Than Usual’ Allergic Reactions
California’s state epidemiologist urged Covid-19 vaccine providers Sunday to pause distribution of one Moderna vaccine lot while the manufacturer and federal government investigate a “higher than usual” number of allergic reactions—which are still extremely rare—temporarily stopping potentially thousands of vaccines from being administered as California faces a Covid-19 surge.
Forbes